ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 121 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $269,000 | -66.2% | 9,000 | -50.0% | 0.02% | -66.7% |
| Q2 2021 | $797,000 | -0.3% | 18,000 | 0.0% | 0.05% | -6.9% |
| Q1 2021 | $799,000 | -19.0% | 18,000 | 0.0% | 0.06% | -23.7% |
| Q4 2020 | $987,000 | +140.1% | 18,000 | 0.0% | 0.08% | +117.1% |
| Q3 2020 | $411,000 | +9.0% | 18,000 | 0.0% | 0.04% | +2.9% |
| Q2 2020 | $377,000 | +50.2% | 18,000 | 0.0% | 0.03% | +25.9% |
| Q1 2020 | $251,000 | -38.8% | 18,000 | 0.0% | 0.03% | -27.0% |
| Q4 2019 | $410,000 | +95.2% | 18,000 | 0.0% | 0.04% | +76.2% |
| Q3 2019 | $210,000 | -22.2% | 18,000 | 0.0% | 0.02% | -12.5% |
| Q2 2019 | $270,000 | -14.6% | 18,000 | 0.0% | 0.02% | -20.0% |
| Q1 2019 | $316,000 | +18.4% | 18,000 | 0.0% | 0.03% | +11.1% |
| Q4 2018 | $267,000 | -39.7% | 18,000 | 0.0% | 0.03% | -35.7% |
| Q3 2018 | $443,000 | +25.5% | 18,000 | 0.0% | 0.04% | +20.0% |
| Q2 2018 | $353,000 | – | 18,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |